Vigilare Wealth Management Immunity Bio, Inc. Transaction History
Vigilare Wealth Management
- $256 Million
- Q2 2025
A detailed history of Vigilare Wealth Management transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Vigilare Wealth Management holds 11,700 shares of IBRX stock, worth $31,005. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,700Holding current value
$31,005% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding IBRX
# of Institutions
248Shares Held
80.5MCall Options Held
1.25MPut Options Held
2.73M-
Vanguard Group Inc Valley Forge, PA20.3MShares$53.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$30.3 Million0.0% of portfolio
-
State Street Corp Boston, MA7.58MShares$20.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA4.29MShares$11.4 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA3.45MShares$9.13 Million0.07% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $1.06B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...